NSC | Compound | Enrichment | Correlation |
---|---|---|---|
NSC 703544 | Null | 0.0430505868034761 | 0.30166196 |
NSC 707832 | Null | 0.0430505868034761 | 0.33096329 |
NSC 709440 | Null | 0.0430505868034761 | -0.18416299 |
NSC 714379 | Null | 0.0430505868034761 | 0.4306307 |
NSC 722854 | 1,4-di-N-oxide-2-phenylcarbonyl-3-trifluoromethylquinoxaline | 0.0430505868034761 | 0.29674369 |
NSC 727087 | 16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-17-oxo-5-androsten-3a-yl acetate | 0.0430505868034761 | 0.1899906 |
NSC 728035 | 1N-{2-[7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[ e]pyrrolo[1,2-a][1,4]diazepin-8-yloxy]ethyl}-2-[8-benzyloxy- 7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrro lo[1,2-a][1,4]di | 0.0430505868034761 | 0.21634332 |
NSC 728038 | 2[(3,4-dicloro)benzylamino]-3-phenyl-5,7-diamino quinoxaline | 0.0430505868034761 | 0.35884034 |
NSC 733504 | Everolimus | 0.0430505868034761 | -0.24281268 |
NSC 736041 | 7-(5-diethylaminopentyloxy)-5-hydroxy-2-phenyl-4H-4-chromeno ne | 0.0430505868034761 | 0.2578665 |